 |
|
| Our Speakers |
Prof.Mahendra S Rao. M.D., Ph.D
Head of Center for Regenerative Medicine. NIH, Bethesda,USA.
Key Note address during the inaugural session.
.....................................................................
Dr. Geeta Jotwani
Assistant Director, General Indian Council Medical Research Division of Basic Medical Sciences
.....................................................................
Dr Stephen Minger,
Global Head (R&D), GE Healthcare, UK
.....................................................................
Dr. Mohan Vemuri, Ph.D
Director, R&D, Stem Cells, Life Technologies.
.....................................................................
Dr. Maria Carolina Oliveira, MD, PhD,
Hospital das Clinicas de Ribeirao Preto - USP
School of Medicine of Ribeirao Preto, University of Sao Paulo, Ribeirao Preto, Brazil
.....................................................................
Dr. Uma Lakshmipathy, Ph.D.
Associate Director, R&D Primary and Stem Cell Systems Life Technologies, CA, USA.
.....................................................................
Prof. Raghu Vemuganti, PhD
Associate Professor Department of Neurological Surgery Clinical Science Center Madison WI USA.
.....................................................................
Prof. Radhika Pochampally, Ph.D.
Assistant Professor Department of Pharmacology Tulane Center for Stem Cell Research and Regenerative Medicine New Orleans, LA, USA
.....................................................................
Dr. Ashok Khar
Director, Cell and Molecular Biology Res. CTD, Apollo Hospitals, Hyderabad.
.....................................................................
Professor Sheila MacNeil, BSc, Ph.D
Professor of Tissue Engineering The Kroto Research Institute North Campus, University of Sheffield Broad Lane, Sheffield, UK.
.....................................................................
Bruce Whitelaw, Ph.D
Professor of Animal Biotechnology, Head of Division, The Roslin Institute and Royal (Dick) School of Veterinary Studies, Division of Developmental Biology, University of Edinburgh Easter Bush Campus Midlothian Scotland UK.
.....................................................................
Dr. Deepa Ghosh, M.Pharm.,PhD.
Group Head, Tissue Engineering Dept., Reliance Life Sciences Pvt. Ltd. DALC- Life Sciences Center, Mumbai.
.....................................................................
Dr. Hidenori Akutsu, MD.,PhD.
National Center for Child Health and Development National Medical Center for Children and Mothers Research Institute Tokyo, Japan.
.....................................................................
Mr. B N Manohar
CEOStempeutics Research Pvt. Ltd, Bangalore.
.....................................................................
Dr. Anish Sen Majumdar,
Chief Scientific Officer Stemeputics Research Pvt. Ltd.
.....................................................................
Prof Geeta K Vemuganti, MD, DNB, FAMS, FICP
Dean, School of Medical Sciences University of Hyderabad.
.....................................................................
Dr. Olexander L. Kukharchuk,
Director EmProCell Clinical Research Navi Mumbai, India
.....................................................................
Dr. Philip G. Vanek, PhD,
Head of Innovation, Lonza Bioscience, USA.
.....................................................................
Dr. Aroop Kumar Dutta, PhD,
Managing Director, ExCel Matrix Biological Devices P.Ltd. Hyderabad, India
.....................................................................
Dr. Jayesh Sheth,
Director, Foundation for Research in Genetics & Endocrinology, FRIGE House, Jodhpur Gam Road,
Satellite, Ahmadabad,
.....................................................................
Brig (Dr) Velu Nair, AVSM, VSM,
Professor & Head, Department of Internal Medicine at AFMC, Pune
.....................................................................
Dr. Ramesh Bhonde, PhD,
Professor & Dean,
Manipal Institute of Regenerative Medicine, Bangalore, India
.....................................................................
Dr. Jayesh Sheth,
Director, Institute of Human Genetics, Ahmedabad, India
.....................................................................
Dr. Vivek Tanavde, PhD,
Principal Investigator, Bioinformatics Institute, Singapore
.....................................................................
Brig (Dr) Velu Nair, AVSM, VSM,
Professor & Head, Department of Internal Medicine at AFMC, Pune
.....................................................................
|
|
|
|
|
|
|
 |
|
 |
|
| ABOUT FABA |
The Federation of Asian Biotechnology Associations is a non-profit registered society having its headquarters in Hyderabad with Dr.B.S.Bajaj as Secretary General, engaged in activities related to promoting biotechnology in Asian countries.
|
| FABA with its beginnings in 2004 has achieved a significant landmark in creating a common platform for interaction among member countries and discuss the issues of common interests for improving the biotech space. |
| FABA has developed a strong network base in 20 Asian countries (Bangladesh, China, Indonesia, India, Iran, Israel, Japan, Kazakhstan, Malaysia, Nepal, Pakistan, Philippines, Russia, Saudi Arabia, South Korea, Singapore, Sri Lanka, Thailand, Turkey and UAE) and has cooperative arrangements with some organizations in Europe and USA. |
| FABA has been organizing Bio-Asia Conference since 2004 and this conference has become an International Brand, where delegates/ business firms from India and various countries are participating, discussing and exploring various business opportunities. |
| In 2002, the first international conference on Stem Cell was organized by the All India Biotech Association – South Chapter (part of FABA) at Hyderabad under able guidance of Dr. B S Bajaj and was received with overwhelming response. While the amount of research at that time was very primitive more that 50,000 reports over the past three years have been published on different aspects of Stem Cell Research and Therapy. With the changed scenario, FABA hopes to spur stem cell research and regenerative medicines around the world through this international conference.
|
| FABA is exempted from Income Tax under Section 12A and 80G. FABA has been organizing Bio-Asia Annual Conference since 2004 and this conference has become an International Brand, where delegates/ business Organizations from India and various countries participate to discuss and explore various business opportunities. |
|
| |
|
|
|
|
|
 |
|
 |
|
